Education
About Us
Working with TipRanks
Follow Us
MetaVia (MTVA)
NASDAQ:MTVA
MTVA Stock Chart & Stats
$0.78
-$0.13(-5.60%)
At close: 4:00 PM EST
$0.78
-$0.13(-5.60%)
Day’s Range― - ―
52-Week Range$0.56 - $2.75
Previous CloseN/A
Volume36.62K
Average Volume (3M)3.42M
Market Cap
$26.13M
Enterprise Value-$7.66M
Total Cash (Recent Filing)$17.59M
Total Debt (Recent Filing)$98.00K
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Mar 26, 2026EPS Estimate
-0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding24,197,810
10 Day Avg. Volume118,677
30 Day Avg. Volume3,419,960
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.99
Price to Sales (P/S)0.00
P/FCF Ratio-0.64
Enterprise Value/Market Cap-0.29
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit547.02
Enterprise Value/Ebitda0.48
Forecast
1Y Price Target
$9.67Price Target Upside1139.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical Data PresentationMetaVia shares are up stemming from a positive data presentation for its MASH asset, Vanoglipel, at the AASLD meeting.
Development OpportunitiesThe possibility of a combination therapy with vanoglipel (DA-1241) provides MTVA a unique opportunity to capitalize on the shifting MASH treatment landscape.
Program SuccessDA-1241 met its Phase 2a objective with improvements across multiple noninvasive liver biomarkers, which the FDA is increasingly treating as potential surrogate endpoints.
Bears Say
MetaVia News
MTVA FAQ
What was MetaVia’s price range in the past 12 months?
MetaVia lowest stock price was $0.56 and its highest was $2.75 in the past 12 months.
What is MetaVia’s market cap?
MetaVia’s market cap is $26.13M.
When is MetaVia’s upcoming earnings report date?
MetaVia’s upcoming earnings report date is Mar 26, 2026 which is in 115 days.
How were MetaVia’s earnings last quarter?
MetaVia released its earnings results on Nov 06, 2025. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.25 by $0.11.
Is MetaVia overvalued?
According to Wall Street analysts MetaVia’s price is currently Undervalued.
Does MetaVia pay dividends?
MetaVia does not currently pay dividends.
What is MetaVia’s EPS estimate?
MetaVia’s EPS estimate is -0.16.
How many shares outstanding does MetaVia have?
MetaVia has 24,197,810 shares outstanding.
What happened to MetaVia’s price movement after its last earnings report?
MetaVia reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.25. Following the earnings report the stock price went down -15%.
Which hedge fund is a major shareholder of MetaVia?
Currently, no hedge funds are holding shares in MTVA
Company Description
MetaVia
MetaVia (MTVA) is a technology company operating in the digital and virtual reality sectors, focusing on creating immersive virtual environments and experiences. The company develops and offers a range of products and services that enable users to engage in virtual social interactions, entertainment, and commerce through advanced VR platforms and applications.
MTVA Stock 12 Month Forecast
Average Price Target
$9.67
▲(1139.74% Upside)
Technical Analysis
ProMIS Neurosciences
―
Leap Therapeutics
―
Citius Pharmaceuticals
―
Rallybio
―
Kairos Pharma, Ltd.
―
Ownership Overview
42.73% Insiders
0.41% Mutual Funds
0.29% Other Institutional Investors
56.04% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---